Modeus and WellSky partner to deliver electronic controlled drug management to global markets
Australian healthcare software company Modeus is thrilled to announce a partnership with WellSky International Ltd, providers of the UK’s leading digital medicines management platform (Pharmacy, EPMA and Chemotherapy).
Under the agreement, WellSky will sell a branded version of HS8 called “WellSky CD Manager” to its customers in Ireland and the UK, with plans to extend to the Netherlands, Belgium, Norway, Sweden and South Africa in the future.
The solution eliminates the need for controlled drug paper records, which have been identified as a potential source of infection in recent reviews covering hospital hygiene and safety during the
pandemic. It is integrated with WellSky systems to deliver seamless controlled drug management while helping to improve governance and compliance.
Rob Tysall-Blay, CEO of Wellsky International, commented; “WellSky is delighted to partner with Modeus on this journey. CD Manager is an important new addition to the WellSky Medicines Management Platform and provides hospitals with a paperless solution for their controlled drug processes. We anticipate a great deal of interest in this latest expansion to the WellSky suite.
Carl Zufi, CEO of Modeus commented; We are very excited to be partnering with WellSky International to deliver our innovative controlled drug management platform to global markets.
WellSky International has a comprehensive medication management platform and WellSky CD Manager extends and compliments this to provide a fully integrated solution unmatched anywhere else. As the use of controlled drugs in hospitals continues to grow at a rapid rate, the need to move away from inefficient manual paper based systems is critical. WellSky CD Manager has been specifically designed to address this challenge.
About WellSky International
WellSky International Ltd is a wholly owned subsidiary of WellSky Inc which serves more than 14,000 client sites around the world — including hospital systems, blood banks, home health and hospice franchises, government agencies, and human services organisations. For more information on WellSky International Ltd visit www.wellsky.org
Modeus are excited to announce that HS8, our hospital electronic controlled drug register platform, is now live at Peter MacCallum Cancer Centrewards.
HS8 will allow nurses to electronically record controlled drug usage and sign off with their existing Imprivatatap cards, saving time while improving governance. In the absence of face-to-face training due to the pandemic, our online training platform has been crucial for onboarding new users and we expect it to play a big role in future implementations.
Modeus would like to give special thanks to the Pharmacy, IT and Nursing teams at Peter Mac for their collaboration during the rollout of the software-lead controlled drug management solution.
Modeus is thrilled to announce a partnership with Imprivata, a global Healthcare IT security company.
The HS8 integration with Imprivata Confirm ID, an identification workflow, will drive efficiencies by allowing users to confirm register entries within HS8 via card tap or fingerprint authentication instead of manually typing in usernames and passwords.
This partnership will also support secure access to HS8 by providing safeguards to help improve patient safety. This will be achieved by incorporating re-authentication for signing and witnessing across a range of hospital medication transactions. These include stock checks, stock transfers, receipt of stock as well as dispensing from pharmacy, ward and theatre areas.
Modeus exhibited at the Medicines Management conference on the Gold Coast last weekend.
This year, we extended our offering beyond the HS8 software by demonstrating integrations with various hardware such as Automated Dispensing Cabinets, Med Carts and Remote Locks. We also featured an integration with a very popular clinical authentication solution.
We had a significant interest in both the flexible software and hardware options, with one attendee calling the solution a “game changer”. It was great to see delegates visiting the booth after watching Peter Blewitt’s presentation on how a hospital can benefit from an electronic controlled drug register.
Modeus is pleased to announce a partnership with Debetrek, one of Australia’s top healthcare equipment specialists.
The HS8 + Debetrek solution will offer a feature-rich, cost-effective, low-risk option to hospitals wishing to automate their medication management and transition their controlled drug management from paper to digital.
The solution is designed to be customisable for each hospital’s unique needs, offering a high degree of adaptability for different locations.
The flexibility offered through the solution allows hospitals to gradually improve their model of care in line with budgets and other priorities, while maintaining familiarity with a single software solution.
Modeus attended the SHPA 2018 Medicines Management Conference in Brisbane to promote HS8, our new hospital controlled drug register platform.
This year has seen incredible momentum with many hospitals throughout Australia inquiring about HS8 and the SHPA conference was a great reflection of this interest. It provided an opportunity to meet with many hospitals face to face, update them on the latest developments and product enhancements, as well as enabled us to answer many of the questions asked.
Modeus are already looking forward to exhibiting at SHPA 2019 on the Gold Coast!